Krystal Biotech Inc (KRYS)

182.47 -1.75 (-0.95%) USD  |  NASDAQ  |  Nov 14, 10:52
More

Krystal Biotech Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to 2023. Upgrade now.
Date Value
December 31, 2023 --

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

Upgrade
Minimum
2023
Upgrade
Maximum
2023
Upgrade
Average
Upgrade
Median
2023

Research and Development Expense (% of Annual Revenues) Benchmarks

Bioventus Inc Upgrade
ADMA Biologics Inc Upgrade
Alnylam Pharmaceuticals Inc Upgrade
Amicus Therapeutics Inc Upgrade
Apellis Pharmaceuticals Inc Upgrade